Ensuring radiotherapy excellence in SCCHN: a comprehensive cost-effectiveness analysis of holiday treatment compensation versus salvage pathways
Background: Treatment interruptions in squamous cell carcinoma of the head and neck (SCCHN) significantly impair tumor control probability (TCP) due to accelerated repopulation. While compensation strategies are recommended, their implementation is often hindered by perceived economic constraints. To validate the economic sustainability of holiday compensation programs by comparing the cost of avoiding one recurrence against the financial burden of managing salvage pathways. Materials and methods: We utilized a time-driven activity-based costing (TDABC) model to map 11 clinical pathways for SCCHN. Each pathway integrates the total economic burden of a patient’s salvage trajectory, including initial diagnostic staging, specific therapeutic interventions (surgery, reirradiation, or systemic therapy), and comprehensive psycho-oncological and functional support. The economic efficiency of the holiday program was determined by calculating the investment required per recurrence prevented [program cost per patient multiplied by the number needed to treat (NNT)], subjected to a multi-factorial sensitivity analysis on recurrence risk (12–20%) and resource intensity (k = 1 to 4). Results: The holiday compensation program demonstrates economic viability when compared to salvage management. Even under adverse scenarios — high resource intensity and low recurrence risk — the investment required to prevent one recurrence through treatment continuity remains competitive against the costs of established salvage trajectories. Conclusions: Holiday compensation for SCCHN is not a discretionary expense but an objective economic necessity for maintaining treatment integrity. This approach provides a robust, replicable methodology for centers to transition from reactive salvage management to proactive, quality-assured radiotherapy, optimizing clinical outcomes and long-term public health sustainability.
Authors
- María Ángeles Perez Escutia
- Raúl Díaz Fuentes (ORCID: https://orcid.org/0009-0004-6367-3613)
- Eduardo Cabello Murillo (ORCID: https://orcid.org/0000-0001-8305-137X)
- Ángel Gaitán Simón (ORCID: https://orcid.org/0000-0002-2165-1975)
- Marta Manzano Rodríguez
- P. Adaimi
- Rafael D'Ambrosi Centeno
- Ana Isabel Milanés Gaillet
- Gustavo Pozo Rodríguez
Institutions
- Hospital Universitario 12 De Octubre (ES)
Publication Details
- Journal
- Reports of Practical Oncology & Radiotherapy
- Published
- 2026-11-16
- DOI
- https://doi.org/10.5603/rpor.114994
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00